The infrastructure behind cardiac AI.

Dr. Paul Dorian is a Professor of Medicine in the Divisions of Cardiology and Clinical Pharmacology at the University of Toronto and a Staff Cardiac Electrophysiologist at St. Michael's Hospital, where he established the cardiac electrophysiology program in 1990. He has held senior leadership roles including Director of the University of Toronto Division of Cardiology (2009–2019) and President of the Canadian Heart Rhythm Society (2013–2014), and is the recipient of multiple national research and achievement awards.

Dr. Dorian has led and served on steering committees for numerous multicenter clinical trials in arrhythmia care, including major randomized and CIHR-funded studies, and has conducted influential research in ambulatory monitoring, wearable cardiac technologies, sudden cardiac death, atrial fibrillation care, and patient-reported outcomes. He developed several of the most widely used quality-of-life measures in atrial fibrillation, has contributed to multiple Canadian Cardiovascular Society guidelines, published over 580 peer-reviewed papers, and serves as Associate Editor of Electrophysiological Disorders of the Heart.

Dr. Green is a founding figure of Canadian cardiac electrophysiology. He established the Arrhythmia Service at the University of Ottawa Heart Institute (UOHI) in 1983 as its sole electrophysiologist and built it into a national referral centre. He served as Director of the EP Fellowship Program (1983–2017), Director of the ECG Department (1983–2018), and Director of the Inherited Arrhythmia Clinic (2013–2022). He trained under Professor Hein J.J. Wellens at the University of Limburg in Maastricht and is a co-author of the 1984 Circulation paper on programmed ventricular stimulation that helped establish the field.

Dr. Alan Rabinowitz is a cardiologist and Clinical Associate Professor at St Paul's Hospital University of British Columbia, with training from the University of Cape Town and the University of Toronto, and interventional cardiology training at St. Paul's Hospital, Vancouver. He previously served as Director of the Cardiac Intensive Care Unit at St. Paul's and has been actively involved in various positions of healthcare leadership in quaternary health institutions, as well as actively involved in service delivery and innovation in underserved rural and remote communities.

Dr. Rabinowitz's work spans data-driven healthcare, AI in cardiology, and computational biology. He serves on the Canadian Cardiovascular Society AI Advisory Committee, was an advisor to the Royal College of Physicians and Surgeons of Canada, and contributes to health data trust initiatives. He is also engaged in global entrepreneurial efforts to leverage exponential technologies for innovation in healthcare, precision medicine, and collaborative public-private health initiatives.

Dr. Kim Connelly is a clinician-scientist recognized for translational research in diabetic cardiomyopathy, advanced cardiac imaging, and regenerative therapies. He directs the Cardio-Metabolic Research Program at St. Michael's, where his lab integrates machine-learning biomarkers with MRI and echo phenotyping. Dr. Connelly has secured >$15 million in competitive funding and has been a key investigator on cell-based therapy trials for heart failure. His expertise in imaging-defined endpoints complements MaxYield's roadmap toward AI-image data fusion.

Dr. Brett Heilbron completed his undergraduate degree at the University of Cape Town (South Africa), and then practiced as a rural family physician in Newfoundland and Manitoba for 4 years. He completed Internal Medicine and Cardiology training at the University of British Columbia in 1995. He has Level 3 Certification in Cardiac Computed Tomography and is a Diplomate of the Certification Board in Cardiac Computed Tomography and a Fellow of the Society of Cardiovascular Computed Tomography. He has been based at St. Paul's Hospital since 1997, where he has a clinical practice and works in the Cardiac Catheterization Laboratory. He is Medical Director of the Electrodiagnostics program at St. Paul's Hospital and Mount St. Joseph's Hospital, and a Clinical Associate Professor at the University of British Columbia. He is the Cardiology Consultant for Lifelabs British Columbia.

Dr. Marc Deyell is a leading electrophysiologist and clinical researcher whose work spans ventricular-tachycardia ablation, inherited arrhythmic syndromes, and signal-processing innovations. As Director of EP at UBC, he supervises a multi-disciplinary team conducting first-in-human trials of AI-driven ECG analytics—research that underpins MaxYield's validation datasets.